ClinicalTrials.gg
Active, not recruitingNCT07178470Updated Aug 27, 2026

Concordance and Discordance in the Assessment of Volume Status in Home Dialysis Patients: A Comparison of Modified Medical Research Council Dyspnea Scale, Physical Exam, and Point of Care Ultrasound (POCUS)

An interventional study of point-of-care ultrasound (POCUS), specifically lung ultrasound (LUS) and Modified Medical Research Council (mMRC) Dyspnea scale in Fluid Overload, POCUS and Lung Ultrasound, sponsored by Indiana University. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Indiana University · Not applicable, Interventional, and Diagnostic

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 144 studies in Edema with a site in United States — 23 open to participants now, 27 under way, 4 of them phase 3. Edema · United States.

Planned enrollment
35th of 110
90 · median 40
Started
2026
with 9 others
No phase
52 of 144
7 open now
Primary completion
2026-11
later than 7 of 26 live
Registered
137th of 144
by date

Among the 144 studies in Edema with a site in United States, this one is the 35th largest by planned enrollment of the 110 interventional ones that give a count, is one of 10 that started in 2026, is one of 52 with no phase, reaches primary completion later than 7 of the 26 other live ones, and was the 137th registered.

Edema

568 studies on the registry are indexed under Edema; 97 are open to participants now.

Browse Edema studies →

Open to participants now

23 of the 144 studies in Edema with a site in United States are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 56 Edema studies recruiting now, 34 (61%) set no upper age limit and 16 (29%) stop at 75 or younger; 8 take children under 18; 4 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 144 studies in Edema with a site in United States, or all of them as a file.
02

Study summary

Fluid overload (when the body has too much fluid), is one of the reasons why people on home dialysis need to go to the hospital. Fluid overload commonly presents as trouble breathing and leg swelling. Traditionally, doctors check for this by asking patients if they have any symptoms like leg swelling or shortness of breath and by doing a physical exam which includes listening to the lungs or looking for swelling in legs. However, a newer, safe, and non-invasive method called point-of-care ultrasound (POCUS) has become very popular. However, there is not a lot of research yet on how POCUS and LUS (lung ultrasound) specifically help home dialysis patients, including those on peritoneal dialysis or home hemodialysis. Peritoneal dialysis is a way to clean the blood by putting a special fluid into the abdomen through a small tube. The fluid uses the natural lining of the belly as a filter to remove waste and extra water. Home hemodialysis is a treatment where a machine acts like an artificial kidney to clean the blood. Patients get trained to do this themselves at home by connecting to the machine with a couple of needles, which cleans their blood of waste and extra fluid. POCUS, especially a (LUS), has been shown to be useful for dialysis patients in outpatient units.

This study will compare different 3 different methods of detecting fluid overload in adult patients with End-stage kidney disease who are receiving home dialysis: answering various survey questions, completing a physical exam, and a LUS. The study seeks to determine which of these methods is the best method to determine fluid overload.

Read the detailed description

Participants will undergo the following assessments or procedures:

  • Review of medical records, including those from the dialysis center.
  • Blood pressure and weight measurement
  • Rate breathlessness
  • Physical Exam
  • Ultrasound procedure, during which the participant will lie flat on their back with their chest exposed. A small amount of gel will be applied to the skin, and a handheld ultrasound device will be pressed lightly to the chest. Eight specific areas on the chest will be imaged (four on each side) to look for something called "B-lines," which can show if there's extra fluid in your lungs. This ultrasound part of the visit should only take about 10 to 15 minutes in total.

Care will be taken to expose only the area being scanned. A chaperone (someone else in the room) will be present for all female patients. All male patients will be asked if they want a chaperone. If they say yes, a chaperone will be present during the ultrasound procedure. After the ultrasound, study participation is complete.

We expect the entire study from enrollment to the completion of data collection for all subjects, to last 9 months. However, each participant will complete a single study visit, which will last for approximately 30-60 minutes.

03

Conditions studied

  • Fluid Overload
  • POCUS
  • Lung Ultrasound
  • Volume Status

Browse trials for

Keywords

  • pocus
  • fluid overload
  • lung ultrasound
  • volume status
  • modified Medical Research Council Dyspnea Scale
  • mMRC dyspnea scale
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age: Greater than 18 years.
  2. Diagnosis: End-stage kidney disease (ESKD).
  3. Treatment: Receiving home dialysis, either peritoneal dialysis (PD) or home hemodialysis (HHD).
  4. Duration of Home Dialysis: At least three months on home dialysis.

Exclusion criteria

Exclusion Criteria:

  1. Consent: Inability to provide .
  2. Inclusion Criteria: Not meeting any of the inclusion criteria.
  3. Pregnancy.
  4. Urgent-Start PD.
  5. Any other obvious cause of shortness of breath not related to volume overload including but not limited to pneumonia, pneumothorax, advanced and Interstitial lung disease.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Other
    Home Dialysis Participants

    This study includes only one group all of whom get the same testing

    Device: point-of-care ultrasound (POCUS), specifically lung ultrasound (LUS) · Other: Modified Medical Research Council (mMRC) Dyspnea scale · Other: Physical Exam

Interventions

  • Devicepoint-of-care ultrasound (POCUS), specifically lung ultrasound (LUS)

    An eight-zone scanning protocol will be used to count the number of B-lines. Patients will be assigned a score based on the B-line count and categorized as absent, mild, moderate, or severe for fluid overload

    Also known as: Ultrasound device either Phillips or Butterfly

  • OtherModified Medical Research Council (mMRC) Dyspnea scale

    The Modified Medical Research Council (mMRC) Dyspnea scale will be administered to patients to assess patient symptoms, with scores ranging from 0 to +4.

  • OtherPhysical Exam

    Clinicians will perform a physical examination using standard practices to assess for signs of fluid overload, including lower extremity edema, crackles on auscultation, weight gain, and vital signs. Patients will then be categorized as hypovolemic, euvolemic, mild, moderate, or severe volume overloaded. The physicians will be blinded to the patient reported symptoms and the LUS.

06

What researchers measure

Primary outcomes

  1. Agreement between the LUS and physical exam

    Researchers will measure discordance and concordance between the LUS and physical exam. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  2. Agreement between the LUS and mMRC dyspnea scale

    Researchers will measure discordance and concordance between the LUS and mMRC dyspnea scale. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  3. Agreement between the physical exam and mMRc dyspnea scale.

    Researchers will measure discordance and concordance between the physical exam and mMRc dyspnea scale. A pair is concordant if the observation ranking higher on one variable also ranks higher on the second measure. The pair is discordant if the observation ranking higher on one endpoint measure and ranks lower on the other. The pair is tied if the subjects have the same classification on both measures.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

Secondary outcomes

  1. Correlation of mMRC dyspnea scale and blood pressure

    Researchers will evaluate whether a patient's subjective symptoms (such as their level of shortness of breath) gets worse in direct proportion to the patient's blood pressure. Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  2. Correlation of mMRC dyspnea scale and weight

    Researchers will evaluate whether a patient's subjective symptoms (such as their level of shortness of breath) gets worse in direct proportion to the patient's weight. Weight will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  3. Correlation of LUS and blood pressure

    Researchers will evaluate whether ultrasound scoring gets worse in direct proportion to blood pressure (i.e., does a higher B-line count correlate with higher blood pressure). Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  4. Correlation of LUS and weight

    Researchers will evaluate whether ultrasound scoring gets worse in direct proportion to weight (i.e., does a higher B-line count correlate with higher weight). Weight will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  5. Correlation of physical exam and blood pressure

    Researchers will evaluate whether physical exam assessment of volume status gets worse in direct proportion to blood pressure (i.e., does a higher volume overload correlate with higher blood pressure). Blood pressure will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

  6. Correlation of physical exam and weight

    Researchers will evaluate whether physical exam assessment of volume status gets worse in direct proportion to weight (i.e., does a higher volume overload correlate with higher weight). Weight will be measured using an automated machine regularly used in the dialysis clinic.

    Time frame: Each participant will be involved in the study for 30-60 minutes, during which all interventions are performed

07

Study locations

1 site
  • Davita Home Dialysis of Indianapolis
    Indianapolis, Indiana 46260, United States
08

References and documents

Publications

  • Leidi A, Soret G, Mann T, Koegler F, Coen M, Leszek A, Dubouchet L, Guillermin A, Kaddour M, Rouyer F, Combescure C, Carballo S, Reny JL, Marti C, Stirnemann J, Grosgurin O. Eight versus 28-point lung ultrasonography in moderate acute heart failure: a prospective comparative study. Intern Emerg Med. 2022 Aug;17(5):1375-1383. doi: 10.1007/s11739-022-02943-9. Epub 2022 Feb 18. PubMed 35181839 ↗
  • Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988 Mar;93(3):580-6. doi: 10.1378/chest.93.3.580. PubMed 3342669 ↗
  • Alexandrou ME, Theodorakopoulou MP, Sarafidis PA. Lung Ultrasound as a Tool to Evaluate Fluid Accumulation in Dialysis Patients. Kidney Blood Press Res. 2022;47(3):163-176. doi: 10.1159/000521691. Epub 2022 Jan 10. PubMed 35008093 ↗
  • Maw AM, Hassanin A, Ho PM, McInnes MDF, Moss A, Juarez-Colunga E, Soni NJ, Miglioranza MH, Platz E, DeSanto K, Sertich AP, Salame G, Daugherty SL. Diagnostic Accuracy of Point-of-Care Lung Ultrasonography and Chest Radiography in Adults With Symptoms Suggestive of Acute Decompensated Heart Failure: A Systematic Review and Meta-analysis. JAMA Netw Open. 2019 Mar 1;2(3):e190703. doi: 10.1001/jamanetworkopen.2019.0703. PubMed 30874784 ↗
  • van Eck van der Sluijs A, Bonenkamp AA, van Wallene VA, Hoekstra T, Lissenberg-Witte BI, Dekker FW, van Ittersum FJ, Verhaar MC, van Jaarsveld BC, Abrahams AC; DOMESTICO study group. Differences in hospitalisation between peritoneal dialysis and haemodialysis patients. Eur J Clin Invest. 2022 Jun;52(6):e13758. doi: 10.1111/eci.13758. Epub 2022 Feb 15. PubMed 35129213 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Nov 2026, 10 months after the start.

Of 153 non-industry interventional studies with no phase under Edema, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's planned 10 months is close to that.

Counting every sponsor, half of 168 studies reached it within 11 months; a quarter within 6 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2025
First posted
Sep 17, 2025
StartActual
Jan 9, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Nov 30, 2026
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07178470
Lead sponsor
Indiana University
Responsible party
Nupur Gupta (Associate Professor of Clinical Medicine, Indiana University) — Principal investigator
First posted
Sep 17, 2025
Start date
Jan 9, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Nov 30, 2026 (estimated)
Last update
Aug 27, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion